CD34 and gallbladder cancer: For instance, in gallbladder cancer, the CD34+CD90+ endothelial cell subset undergoes endothelial-to-mesenchymal transition (EndoMT) via activation of the TGF-β signaling pathway, acquiring stromal-like properties that enhance its capacity to promote tumor invasion and metastasis [65].